Solentim, the trusted global leader for solutions to create, isolate, and characterize the highest value cells for the development of new biological medicines, is pleased to announce that it will be presenting at 5th Annual MarketsandMarkets Bioprocessing of Biotherapeutics, 20-21st of May. Duncan Borthwick, Global Marketing Manager at Solentim, will present on Thursday 20th of …
Confluency, the percent area of a microplate well visually covered by cells, is used in cell biology as a trigger for key events including initiation of cell-based assays, transfection and passaging. An artificial neural network is a scalable, adaptive structure that when compared to traditional image processing methods has the advantages of being able to …
Bournemouth, UK, 5th May 2021 / Solentim, the trusted global leader in workflows for antibody and cell-based therapies, today announced an expansion of its European operations. The company has established a new EU entity based in Ireland to facilitate frictionless business within the EU and it has opened a new warehousing and logistics hub in Germany, to better serve …
Solentim, the trusted global leader for solutions to create, isolate, and characterize the highest value cells for the development of new biological medicines, is pleased to announce that it will be presenting at American Society of Gene & Cell Therapy 24th Annual Meeting, 11-14th May. Dr Ian Taylor, Chief Business Officer, Solentim, will present on Thursday 13th May, …
Read more Solentim will present at ASGCT 24th Annual Meeting
Enjoy a tour of Solentim’s cell biology labs and see our technology in action. Featuring VIPS, Cell Metric, ICON and our new data management system, STUDIUS, hear from our lab scientists and learn how Solentim’s assurance rich technology can advance cell line development processes. https://www.solentim.com/virtual-demo-resource-hub-2/
Read more NEW! Virtual Demo. A tour of our labs and technology.
A project consortium involving Solentim, ValitaCell and Microcoat has successfully developed an integrated technology platform for biologics and cell therapy. In 2019, the consortium partners raised €3.5M to advance the project which has culminated in the launch of the ICON™ instrument by Solentim. ICON™ is designed to enhance commercial laboratory workflows involved in development of new therapeutic antibodies. …
Read more Cell line development partners deliver technology breakthrough
